Back to News
Market Impact: 0.3
Bausch + Lomb Gains CE Mark For SeeLyra Femtosecond Laser
Source: Nasdaq
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Bausch + Lomb received EU CE Mark approval for SeeLyra, its next-generation femtosecond laser platform. The clearance enables commercialization in the European Union and supports expansion of the company's ophthalmic surgical technology portfolio.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
BLCO0.75
More News
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Meta announces $95 billion stock offering to fund AI expansion
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- Apple says it will replace iPhone Duo units showing screen problems
- USTR Greer tells EU that loan to Airbus threatens trade truce on aircraft financing
- Blackstone-backed AirTrunk secures $2.98 bln green loan for Sydney campus